QuickView for n 1-( 3-( 3- oxo- 2, 3- dihydrobenzo( 1, 4) oxazin- 4- yl) propyl) piperidin- 4- yl)- 2- phenylacetamide

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

There were no matches for n 1-( 3-( 3- oxo- 2, 3- dihydrobenzo( 1, 4) oxazin- 4- yl) propyl) piperidin- 4- yl)- 2- phenylacetamide

There were no clinical trials for n 1-( 3-( 3- oxo- 2, 3- dihydrobenzo( 1, 4) oxazin- 4- yl) propyl) piperidin- 4- yl)- 2- phenylacetamide